Omega-3 health claim
This article was originally published in The Tan Sheet
Executive Summary
FDA amends, shortens qualified health claim for fatty acids/coronary heart disease. In Feb. 8 letter to Emord & Associates, agency says it will allow use of the claim: "Consumption of omega-3 fatty acids may reduce the risk of coronary heart disease. FDA evaluated the data and determined that, although there is scientific evidence supporting the claim, the evidence is not conclusive." Supplements bearing claim must not recommend intake exceeding 2 g/day EPA and DHA. Pearson plaintiffs had complained original 78-word claim, approved in October 2000, failed to accurately summarize scientific knowledge about fatty acids and was too lengthy (1"The Tan Sheet" Nov. 6, 2000, p. 3)...
You may also be interested in...
Structure/Function, Health Claims Often Indistinguishable, OIG Report Finds
Structure/function claims are often unclear regarding supplements' intended use, according to a March 4 report released by the Department of Health & Human Services' Office of the Inspector General
Omega-3/Heart Disease Qualified Supplement Health Claim Allowed
Dietary supplements bearing a qualified health claim for omega-3 fatty acids and coronary heart disease risk reduction must recommend a maximum daily intake of 2 g EPA and DHA, FDA announced Oct. 31.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.